UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000017828 |
|---|---|
| Receipt number | R000020652 |
| Scientific Title | Phase II trial of the addition of bevacizumab to alectinib beyond progressive disease in ALK-positive advanced non-small-cell lung cancer. |
| Date of disclosure of the study information | 2015/06/05 |
| Last modified on | 2019/02/22 16:01:26 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/06/05 22:06:51 | ||
| 2 | Update | 2015/06/05 22:09:57 | Recruitment status |
|
| 3 | Update | 2016/06/05 09:46:34 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2019/02/22 16:01:26 | Recruitment status |
